---
pmid: '29364502'
title: ARRDC3 suppresses colorectal cancer progression through destabilizing the oncoprotein
  YAP.
authors:
- Shen X
- Sun X
- Sun B
- Li T
- Wu G
- Li Y
- Chen L
- Liu Q
- Cui M
- Zhou Z
journal: FEBS Lett
year: '2018'
full_text_available: false
doi: 10.1002/1873-3468.12986
---

# ARRDC3 suppresses colorectal cancer progression through destabilizing the oncoprotein YAP.
**Authors:** Shen X, Sun X, Sun B, Li T, Wu G, Li Y, Chen L, Liu Q, Cui M, Zhou Z
**Journal:** FEBS Lett (2018)
**DOI:** [10.1002/1873-3468.12986](https://doi.org/10.1002/1873-3468.12986)

## Abstract

1. FEBS Lett. 2018 Feb;592(4):599-609. doi: 10.1002/1873-3468.12986. Epub 2018
Feb  13.

ARRDC3 suppresses colorectal cancer progression through destabilizing the 
oncoprotein YAP.

Shen X(1), Sun X(1), Sun B(2), Li T(2), Wu G(2), Li Y(2), Chen L(3), Liu Q(1), 
Cui M(2), Zhou Z(1).

Author information:
(1)College of Life Sciences, Shandong Agricultural University, Tai'an, Shandong, 
China.
(2)Department of Anorectum, Qianfo Mount Hospital affiliated to Shandong 
University, Ji'nan, Shandong, China.
(3)Jiangxi University of Traditional Chinese Medicine, Nanchang, China.

Although colorectal cancer (CRC) is a prevalent malignancy of the digestive 
system, the underlying mechanisms of CRC tumorigenesis are still elusive. 
Arrestin-related domain-containing protein-3 (ARRDC3) has been reported to 
promote lysosome-mediated protein degradation. In the present study, we find 
that the expression of ARRDC3 is downregulated in CRC specimens. 
Mechanistically, we reveal that ARRDC3 binds and decreases expression of the 
oncoprotein YAP, the cotranscription factor of the Hippo pathway. The regulation 
of the Hippo pathway by ARRDC3 is conserved from Drosophila to mammals. 
Furthermore, we demonstrate that ARRDC3 plays an anti-oncogenic role in CRC 
progression by promoting YAP degradation. Finally, we show that ARRDC3 increases 
the sensitivity of CRC cells toward chemotherapeutic drugs. Taken together, our 
findings point to ARRDC3 as a potential target for CRC treatment.

Â© 2018 Federation of European Biochemical Societies.

DOI: 10.1002/1873-3468.12986
PMID: 29364502 [Indexed for MEDLINE]
